PLEOPHARMA, INC. REPORTS POSITIVE PHASE 2b CLINICAL TRIAL DATA FOR MITIGATION OF CANNABIS WITHDRAWAL: A POTENTIAL FIRST IN CLASS TREATMENT ...Middle East

Phase 2b Study for PP-01 Met Its Primary Endpoint End of Phase 2 Meeting with FDA Completed Phase 3 Preparations Underway PHOENIXVILLE, Pa., Sept. 5, 2024 /PRNewswire/ -- PleoPharma, Inc., a privately held company focused on cannabis related health issues, announced today Phase 2b study...

Hence then, the article about pleopharma inc reports positive phase 2b clinical trial data for mitigation of cannabis withdrawal a potential first in class treatment was published today ( Thursday 05/09/2024 - 02:32 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PLEOPHARMA, INC. REPORTS POSITIVE PHASE 2b CLINICAL TRIAL DATA FOR MITIGATION OF CANNABIS WITHDRAWAL: A POTENTIAL FIRST IN CLASS TREATMENT )

Also on site :

• '80s Hard Rock Band Announces Massive 2026 Tour With Iconic Special Guest
• Insomnia Cookies is Hosting a Valentine's Date Night: Here's How to Score a Reservation
• After Almost 50 Years, A Cult Sci-Fi Favorite Is Officially Coming Back